Bio
We haven't found any bio for you yet.
Researcher Links
Loading links...
Publications by Type
Loading publications…
The last 5 uploaded publications
MM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies
Konstantinos Giannakas, Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Eirini Solia, Foteini Theodorakakou, Vasiliki Spiliopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Kostantina Taouxi, Alexandra Papadimou, Christine‐Ivy Liacos, Maria Gavriatopoulou, Ourania Tsitsilonis, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos (2025). MM-434: Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)02604-7.
Article23 days agoPOSTER: MM-434 Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies
Konstantinos Giannakas, Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Eirini Solia, Foteini Theodorakakou, Vasiliki Spiliopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Μαρία Ρούσσου, Evangelos Eleutherakis‐Papaiakovou, Kostantina Taouxi, Alexandra Papadimou, Christine‐Ivy Liacos, Maria Gavriatopoulou, Ourania Tsitsilonis, Evangelos Terpos, Efstathios Kastritis, Meletios A Dimopoulos (2025). POSTER: MM-434 Identifying Circulating Tumor Cells via Advanced Flow Cytometry as Emerging Prognostic Indicators in Patients With Asymptomatic Monoclonal Gammopathies. , 25, DOI: https://doi.org/10.1016/s2152-2650(25)01259-5.
Article23 days agoPatterns of minimal residual disease trajectories in 323 newly diagnosed patients with multiple myeloma and correlation with progression-free survival
Panagiotis Malandrakis, Ioannis V. Kostopoulos, Ioannis Ntanasis-Stathopoulos, Charalampos Filippatos, Sotirios Manganas, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Kanellias, Vasiliki Spiliopoulou, Magdalini Migkou, Despina Fotiou, Foteini Theodorakakou, Efstathios Kastritis, Maria Gavriatopoulou, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos (2025). Patterns of minimal residual disease trajectories in 323 newly diagnosed patients with multiple myeloma and correlation with progression-free survival. , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-2216.
Article23 days agoCirculating tumor cells (CTCs) improve risk stratification according to the second revision of the international staging system (R2-ISS) and the ims-IMWG consensus genomic staging (CGS) in newly diagnosed multiple myeloma (NDMM): An analysis from the european CTC consortium.
Mattia D’Agostino, Esperanza Martín‐Sánchez, David Žihala, Ioannis V. Kostopoulos, Juan-José Garcés, Noemí Puig, Giuseppe Bertuglia, Tereza Ševčíková, Tom Cupedo, Mark van Duin, Jonathan J. Keats, Elena Zamagni, Philippe Moreau, Sonja Zweegman, Jill Corre, Mario Boccadoro, Meletios A Dimopoulos, Roman Hájek, Bruno Paiva, Pieter Sonneveld, Annemiek Broijl, Evangelos Terpos, Tomáš Jelı́nek, Jesús F. San Miguel, Francesca Gay, Luca Bertamini (2025). Circulating tumor cells (CTCs) improve risk stratification according to the second revision of the international staging system (R2-ISS) and the ims-IMWG consensus genomic staging (CGS) in newly diagnosed multiple myeloma (NDMM): An analysis from the european CTC consortium.. , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-364.
Article23 days agoCirculating tumor cells (CTCs) combined with frailty index offer an improved stratification system for transplant-ineligible newly diagnosed multiple myeloma patients
Ioannis V. Kostopoulos, Ioannis Ntanasis‐Stathopoulos, Panagiotis Malandrakis, Pantelis Rousakis, Nikolaos Tsakirakis, Evangelos Eleutherakis‐Papaiakovou, Nikolaos Angelis, Vasiliki Spiliopoulou, Chrysanthi Panteli, Rodanthi Syrigou, Panagiotis Bakouros, Eirini Solia, Georgia Dimitrakopoulou, Despina Fotiou, Magdalini Migkou, Nikolaos Kanellias, Maria Gavriatopoulou, Efstathios Kastritis, Ourania Tsitsilonis, Meletios A Dimopoulos, Evangelos Terpos (2025). Circulating tumor cells (CTCs) combined with frailty index offer an improved stratification system for transplant-ineligible newly diagnosed multiple myeloma patients. , 146(Supplement 1), DOI: https://doi.org/10.1182/blood-2025-5791.
Article23 days ago